HomeREGULATORY
REGULATORY

Hemophilia A Treatment Hemlibra, Zoster Vaccine Shingrix Clear MHLW Panel
(Mar.5.2018)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on March 2 backed approval for Chugai Pharmaceutical’s hoped-to-be-blockbuster hemophilia A treatment emicizumab and Shingrix, a novel zoster vaccine developed by GlaxoSmithKline. Their approvals are expected by the end of this month ...
(LOG IN FOR FULL STORY)